A Kayak.com For Drug Trial Sign-Ups?
An entrepreneur is taking a page from the travel industry with a new tool he thinks could tackle a long-standing inefficiency that's hobbled the pharmaceutical industry for years -- matching scientists to patients with the disease.
Bloomberg:
Drug Tests Take Cue From Travel Site To Fix Industry Headache
Pablo Graiver aims to make signing up for a drug study as easy as booking a flight on the Web. The 47-year-old Argentinian entrepreneur, a former executive at the airfare search engine kayak.com, has designed a new tool that draws from the travel industry to match scientists looking to test experimental medicines with patients suffering from more than a dozen diseases. It pools information patients previously had to piece together from Google searches, doctors and a complicated government-run website. (Kitamura, 3/10)
In other pharmaceutical news, Valeant's CEO says there's no other shoe that's going to drop —
Bloomberg:
Valeant CEO Says No More Surprises, In Meeting With Top Execs
Days after his surprise return from medical leave, Valeant Pharmaceuticals International Inc. Chief Executive Officer Michael Pearson gathered his senior managers at the company’s New Jersey offices to deliver a message: the drugmaker’s businesses were still mostly doing well, and Valeant was not going to go bankrupt. (Langreth, 3/10)
